Related content

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes

By Yamada Kentaro   Nakayama Hitomi   Sato Shuichi   Tajiri Yuji   Kaku Hiroh   Tokubuchi Ichiro   Kato Tamotsu   Soejima Eri   Ohki Tsuyoshi  

Diabetology International, Vol. 5, Iss. 1, 2014-03 ,pp. : 74-77

Springer Publishing Company

Access to resources Recommend Favorite

Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type)

By Vähätalo Markku   Viikari Jorma   Rönnemaa Tapani  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 233-238

Springer Publishing Company

Access to resources Recommend Favorite

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

By Costi María   Dilla Tatiana   Reviriego Jesús   Castell Conxa   Goday Albert  

Acta Diabetologica, Vol. 47, Iss. 1, 2010-12 ,pp. : 169-175

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Insulin Glargine in Type 1 and 2 Diabetes Mellitus

By McKeage K.   Goa K.L.  

Treatments in Endocrinology, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-58

Adis International

Access to resources Recommend Favorite

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

By Hermansen K.   Fontaine P.   Kukolja K.   Peterkova V.   Leth G.   Gall M.-A.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 622-629

Springer Publishing Company

Access to resources Recommend Favorite